UnitedHealth Group completes $101/share acquisition of Amedisys; Amedisys delisted from Nasdaq

AMEDISYS INC

Amedisys shareholders receive $101 per share in cash upon merger close on August 14, 2025.
Outstanding equity awards converted into restricted stock units/options of UnitedHealth Group.
Credit agreement terminated; $399.2M in outstanding obligations repaid.
All Amedisys directors resigned; board reconstituted as subsidiary of UnitedHealth Group.
Amedisys Common Stock delisted from Nasdaq; plans to deregister under Exchange Act.

item 1.02item 2.01item 3.01item 3.03item 5.01item 5.03item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.